---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-017581"
form_type: "8-K"
ticker: "PBYI"
cik: "0001401667"
company_name: "PUMA BIOTECHNOLOGY, INC."
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-13T23:59:55.127962+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Puma Biotechnology announces results of 2023 annual meeting of stockholders

## Summary
- All eight director nominees elected; highest 'for' vote was Cesano at 30,203,447, lowest was Wilson at 26,825,653.
- KPMG LLP ratified as independent auditor for FY2023 with 39,051,453 votes for, 113,960 against.
- Advisory say-on-pay proposal approved: 28,584,098 for, 2,112,789 against, 113,566 abstain.
- Broker non-votes of 8,447,026 recorded on director election and say-on-pay proposals.
- No other proposals or material business conducted at the meeting.

## SEC filing metadata
- accession: 0001437749-23-017581
- form_type: 8-K
- ticker: PBYI
- cik: 0001401667
- company_name: PUMA BIOTECHNOLOGY, INC.
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401667/000143774923017581/0001437749-23-017581-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401667/000143774923017581/pbyi20230615_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-017581
- JSON: https://secwatch.observer/filing/0001437749-23-017581.json
- Plain text: https://secwatch.observer/filing/0001437749-23-017581.txt

## Key facts
- Shareholder Votes
  PUMA BIOTECHNOLOGY, INC. shareholders approved Election of directors at the 2023-06-13 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: Proposal 1: The Company’s stockholders elected the eight nominated directors identified below, each to serve and to hold office for a one-year term until the close of the Company’s next annual meeting of stockholders in 2024 and until their successors have been duly elected and qualified or until their earlier resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401667/000143774923017581/0001437749-23-017581-index.htm
- Shareholder Votes
  PUMA BIOTECHNOLOGY, INC. shareholders approved Advisory vote to approve the compensation of named executive officers at the 2023-06-13 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: Proposal 3: The Company’s stockholders voted to approve, on an advisory basis, the compensation of the Company’s named executive officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401667/000143774923017581/0001437749-23-017581-index.htm
- Shareholder Votes
  PUMA BIOTECHNOLOGY, INC. shareholders approved Ratification of KPMG LLP as independent registered accounting firm for fiscal year ending December 31, 2023 at the 2023-06-13 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: Proposal 2: The Company’s stockholders ratified the selection of KPMG LLP as the Company’s independent registered accounting firm for the fiscal year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401667/000143774923017581/0001437749-23-017581-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.